Literature DB >> 10984345

Mortality surveillance and occupational hazards: the Solutia mortality experience 1980-94.

J J Collins1, S G Riordan.   

Abstract

OBJECTIVES: Several investigators argue that company wide mortalities for recent workers allow early identification of potential workplace hazards. Mortalities for recent workers were compared with published studies of workers with specific exposures in the same company to find whether mortality surveillance results could be used to identify previously unknown health effects from workplace hazards.
METHODS: Relative risks for causes of death in published substance specific studies at the plants were compared with the relative risks in the mortality surveillance of workers 20 or more years after first being employed.
RESULTS: As reported by other companies, low mortalities were found among workers in the mortality surveillance. The mortality surveillance reports often found no increased risk of disease at plants in which substance specific studies had found no effects. However, disease specific relative risks were not found by the mortality surveillance predictions of relative risks in the substance specific studies with increased risk.
CONCLUSION: Mortality surveillance is of limited use for identifying health effects from past workplace exposures to specific materials. The healthy worker and survivor effects, the failure to identify subsets of workers exposed to potentially toxic substances, the typically long induction period between exposure and disease, and the inability of recent mortality levels to reflect historical conditions all may make it difficult to use mortality surveillance to identify workplace hazards. Combining mortality surveillance with studies of workers with potentially toxic exposures helps identify occupational hazards.

Entities:  

Mesh:

Year:  2000        PMID: 10984345      PMCID: PMC1739872          DOI: 10.1136/oem.57.10.710

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  32 in total

1.  Mortalities of workers at the Nitro plant with exposure to 2-mercaptobenzothialzole.

Authors:  J J Collins; M E Strauss; S G Riordan
Journal:  Occup Environ Med       Date:  1999-10       Impact factor: 4.402

2.  The first reported cases of human bladder tumors due to a new carcinogen-xenylamine.

Authors:  W F MELICK; H M ESCUE; J J NARYKA; R A MEZERA; E P WHEELER
Journal:  J Urol       Date:  1955-12       Impact factor: 7.450

3.  Mortality study of workers in the manufacture of vinyl chloride and its polymers.

Authors:  I R Tabershaw; W R Gaffey
Journal:  J Occup Med       Date:  1974-08

4.  Bladder cancer due to exposure to para-aminobiphenyl: a 17-year followup.

Authors:  W F Melick; J J Naryka; R E Kelly
Journal:  J Urol       Date:  1971-08       Impact factor: 7.450

5.  Cancer epidemiologic surveillance in the Du Pont company.

Authors:  S Pell; M T O'Berg; B W Karrh
Journal:  J Occup Med       Date:  1978-11

6.  The mortality experience of workers exposed to tetrachlorodibenzodioxin in a trichlorophenol process accident.

Authors:  J A Zack; R R Suskind
Journal:  J Occup Med       Date:  1980-01

7.  A method for verifying the completeness of cohorts used in occupational mortality studies.

Authors:  G M Marsh; P E Enterline
Journal:  J Occup Med       Date:  1979-10

8.  Human health effects of 2,4,5-T and its toxic contaminants.

Authors:  R R Suskind; V S Hertzberg
Journal:  JAMA       Date:  1984-05-11       Impact factor: 56.272

9.  Mortality among workers from a plastics producing plant: a matched case-control study nested in a retrospective cohort study.

Authors:  G M Marsh
Journal:  J Occup Med       Date:  1983-03

10.  Epidemiologic study of vinyl chloride workers: mortality through December 31, 1972.

Authors:  W C Cooper
Journal:  Environ Health Perspect       Date:  1981-10       Impact factor: 9.031

View more
  1 in total

1.  Mortality in employees at a New Zealand agrochemical manufacturing site.

Authors:  David I McBride; Carol J Burns; G Peter Herbison; Noel F Humphry; Kenneth Bodner; James J Collins
Journal:  Occup Med (Lond)       Date:  2009-03-17       Impact factor: 1.611

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.